11.10.26 -- Implementing AI And Digital Twins In Bioprocessing With Will Olughu, Ph.D.

Hear from this expert about how this company is helping developers turn complex in vivo LVV designs into clinical-ready products, and see the new analytics that reveal what’s really inside your vector.

Single-use bioreactors with turndown ratios up to 20:1 enable wide volume ranges within the same vessel, streamlining seed trains and reducing capital requirements for multi-product operations.

Help shape the future of medicine by building better, safer cell therapies. See how expertise in scalable, GMP-compliant cell engineering can effectively mitigate clinical development risks.

Discover how AI can optimize processes, improve efficiency, and enhance the understanding of cellular processes, ultimately leading to more effective and personalized patient treatments.

Watch part 2 of a four-part series, "Four Common Types Of Cryogenic Studies For Advanced Therapies," to learn about long-term freezing studies and how a therapy will perform at ultra-low temperatures.

In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Will Olughu, Ph.D., global CMC lead and senior principal scientist at Ipsen, to talk about process modeling and AI applications in biopharma manufacturing.